Phase 2 High Grade Serous Ovarian Cancer Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Endometrial CancerPrimary Peritoneal CarcinomaNon-small Cell Lung Cancer+6 more
Genmab764 enrolled66 locationsNCT05579366
Recruiting
Phase 2
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
Cervical CancerSolid TumorHigh Grade Serous Ovarian Cancer+2 more
University of Oklahoma55 enrolled4 locationsNCT05512208
Withdrawn
Phase 2
A Phase II, Signal-Seeking Trial of the Clinical Benefit Rate Associated with Pamiparib in Subjects with Germline or Somatic BRCA1/2 High Grade Serous Ovarian Cancer or carcinosarcoma who have progressed on P-gp substrate chemotherapy or PARP inhibitors with the Presence of an ABCB1 Fusion and the Absence of a BRCA1/2 Reversion
High Grade Serous Ovarian CancerCarcinosarcoma
Australia New Zealand Gynaecological Oncology Group40 enrolled8 locationsACTRN12619000583145